Lb. helveticus fermentates |
Stimulated GLP-1 production, anti-diabetic effect |
11% RSM |
75 |
Fermentates from a range of LAB strains |
Inhibited pancreatic lipase. |
10% RSM |
71 |
Fermentates of Lactobacillus pentosus DPC6004, Lactobacillus salivarius subsp. salivarius DPC6005, Pediococcus pentosaceus DPC6006, Lactobacillus murinis DPC6002, and Lb. murinis DPC6003 |
Anti-Salmonella effect in pigs |
All strains in 10% RSM with yeast extract except Lb. salivarius (10% RSM only without yeast extract). |
83 |
Lb. acidophilus SBT2074 |
Inhibited Escherichia coli 3544 |
10% RSM |
84 |
Fermentates of Lb. animalis DPC6134 (NCIMB 41355) |
ACE inhibitory activity |
2.5% sodium caseinate substrate with 0.5% glucose |
100 |
26 LAB fermentates |
ACE inhibitory activity |
9.5% RSM |
101 |
34 LAB fermentates. Most potent was Pediococcus acidilactici SDL1414 |
ACE inhibitory activity |
20% Soybean protein isolates |
104 |
Fermentates from Lactobacillus jensenii ATCC 25258, Lb. acidophilus ATCC 4356, and Leuconstoc mesenteroides subsp. cremoris
|
Antioxidant activity |
Fresh pasteurized skim milk |
105 |
Fermentates from Lb. delbrueckii and Lb. fermentum (ADR-159) |
Mice demonstrated increased sociability and decreased baseline corticosterone |
Culture medium containing lactosemonohydrate, casein peptone, yeast extract, sodium acetate, dipotassiumphosphate). |
106 |